Skip to main content
Order CJC-1295

A curated front page of the CJC-1295 research — the GHRH-analog pharmacology, the DAC-vs-no-DAC half-life split, and the finding that growth-hormone pulsatility survives continuous stimulation, every study laid out as its own card.

WHY THE TWO FORMS LAST DIFFERENTLY

CJC-1295 DAC vs No-DAC: what prolongs the action

The compound has forms that stay in blood for different lengths of time. With the added link, a protein carries the compound through blood. You'll see why evidence about one form can't describe both.

Findings about the longer formWhat the study amounts mean
On this page

On this page

How CJC-1295 DAC travels with a blood protein

CJC-1295 DAC travels through blood joined to the protein albumin. An added link holds the compound to that protein [2]. Think of a passenger riding a slow-moving bus. The protein leaves blood slowly and carries the linked compound with it.

The joined compound and protein weigh about 66 kilodaltons (units used for tiny substances). That figure describes the combined weight, rather than an amount to use. Healthy adults given repeated shots had higher levels of their liver's growth-supporting hormone. The higher levels lasted up to 28 days [3], without establishing lasting benefit for you.

Healthy adults showed a growth-hormone rise lasting days after receiving one shot [3]. The brief spurts of hormone release also kept their timing [1]. Those findings show what changed in people's blood. You can't tell how you'd feel or what the shorter form does.

Researchers also tested CJC-1295 in mice lacking the body's growth-hormone-releasing hormone. Giving 2 micrograms every 24 hours restored weight and length [4]. Shots 48-72 hours apart helped the mice's growth less. Those mouse-study amounts and gaps don't establish a treatment schedule for you.

Why CJC-1295 No-DAC leaves blood sooner

CJC-1295 no DAC lacks the link joining the compound to albumin. Four changes still protect the chain from breaking down. But the compound can't travel with the blood protein that stays around longer. You're looking at a shorter-lasting form, rather than simply a weaker one.

Minutes to hours is the length of action of CJC-1295 without DAC. With DAC, the rise in hormone levels can last days. Your expectations need evidence about the form actually tested. Longer-form amounts and results don't establish what the shorter form does.

Why CJC-1295 No-DAC leaves blood sooner

What Modified GRF (1-29) means when you see the name

The form named Modified GRF 1-29 works briefly and carries no DAC. Its chain contains 29 amino acids (protein parts joined together into a chain). Four changed parts slow breakdown, but no link joins albumin. That leaves the compound with a shorter action than the linked form.

Advertisements and online discussions sometimes use the two names loosely. You might see CJC-1295 used to mean the shorter form. A CJC-1295 study can become misleading if the form isn't named. Check whether the study tested the added link before applying its findings.

What goes wrong when a longer-form result names the shorter form

The longer form's stay in blood helps explain lasting hormone rises [3]. The shorter compound leaves blood sooner, after minutes to hours of action. You need separate evidence for each form about how long effects last. Your expectations about research amounts need that same distinction.

Lasting human hormone rises came from studies of longer-lasting CJC-1295 [3]. The short hormone spurts also continued with CJC-1295 carrying DAC [1]. Mice lacking the natural release hormone grew normally when researchers gave daily shots [4]. Those findings don't prove what the shorter form does for people.

A study's shot timing concerns the form researchers actually used. Copying that timing to another form loses the reason behind it. Ask which form produced the finding you're reading about. The number can be quoted correctly while the compound's name is wrong.

ConjuChem stopped development of the original longer-lasting form. Reports often link a patient death with the halted Phase 2 trial. Public evidence hasn't shown that CJC-1295 caused that death. You're left with unresolved history, without proof of cause or long-term safety.

What rose in adults given CJC-1295 DAC

CJC-1295 DAC has the added link that prolongs its stay in blood. The growth hormone and liver-made growth-supporting hormone in healthy adults' blood both rose [3]. The rises lasted days, without showing whether people felt better. You mostly have human findings about linked CJC-1295, without equivalent tests of the shorter form.

What CJC-1295 DAC study amounts do not establish

Researchers gave one shot containing 30-90 micrograms per kilogram each person weighed [3]. These were tiny amounts scaled to body weight. The DAC form stays in blood days longer than the other form. These experiments in healthy adults haven't established an amount that can treat you.